TAS1R2/TAS1R3 Single-Nucleotide Polymorphisms Affect Sweet Taste Receptor Activation by Sweeteners: The SWEET Project
Nutrients · 08.03.2025 · 17 (6) · 949
DOI: 10.3390/nu17060949 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 08.03.2025. Verfasst von Christine Belloir und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre des Sciences du Goût et de l'Alimentation, The National Centre for Scientific Research (CNRS), National Institute of Agricultural Research (IN…. Hauptthemen laut MEDLINE: Polymorphism, Single Nucleotide, Receptors, G-Protein-Coupled, Sweetening Agents, Taste. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union's Horizon 2020 research and innovation program, European Union’s Horizon 2020 research and innovation program: Sweeteners and Sweetness Enhancers: Impact on Health, Obesity, Safety and Sustainability.
Abstract (Originalsprache)
Background/Objectives: Studies have hypothesised that single-nucleotide polymorphisms (SNPs) in the TAS1R2 and TAS1R3 genes may alter sweet compound detection and eating habits, thereby increasing the risk of obesity. This in vitro study aims to measure the impact of human TAS1R2/TAS1R3 polymorphisms, some of which are thought to be involved in obesity, on the response of the sweet taste receptor to various sweeteners. It also aims to identify new SNPs in an obese population associated with a decrease in or loss of TAS1R2/TAS1R3 function.
Methods
First, the effects of 12 human TAS1R2-SNPs and 16 human TAS1R3-SNPs, previously identified in the literature, on the response of the sweet taste receptor stimulated by 12 sweeteners were investigated using functional cellular assays. Second, a total of 162 blood samples were collected from an obese population (BMI between 25 and 35 kg/m2) involved in the SWEET project. The TaqMan method for SNP genotyping was carried out using DNA extracted from blood samples to identify new SNPs and predict possible/probable TAS1R2/TAS1R3 loss of function.
Results
Although certain human TAS1R2/TAS1R3 SNPs showed reduced receptor response, they were not associated with particular phenotypes. Seven SNPs were predicted to severely impair the human TAS1R2/TAS1R3 response to sweeteners.
Conclusions
Although some TAS1R2- and TAS1R3-SNPs have previously been associated with obesity, our cellular results do not confirm this association and reinforce the hypothesis, put forward by other researchers, that sweet taste perception and sugar consumption are governed by factors other than the TAS1R2 and TAS1R3 genes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre des Sciences du Goût et de l'Alimentation, The National Centre for Scientific Research (CNRS), National Institute of Agricultural Research (INRAE), Institut Agro, Université Bourgogne Europe, F-21000 Dijon, Franc…
ORCID-Profile: Christine Belloir, Adeline Karolkowski, Loïc Briand
Förderung
- European Union's Horizon 2020 research and innovation program
- European Union’s Horizon 2020 research and innovation program: Sweeteners and Sweetness Enhancers: Impact on Health, Obesity, Safety and Sustainability
Zitieren
APA
Belloir, C., Jeannin, M., Karolkowski, A., & Briand, L. (2025). TAS1R2/TAS1R3 Single-Nucleotide Polymorphisms Affect Sweet Taste Receptor Activation by Sweeteners: The SWEET Project. Nutrients, 17(6), 949. https://doi.org/10.3390/nu17060949
Vancouver
Belloir C, Jeannin M, Karolkowski A, Briand L. TAS1R2/TAS1R3 Single-Nucleotide Polymorphisms Affect Sweet Taste Receptor Activation by Sweeteners: The SWEET Project. Nutrients. 2025;17(6):949. doi:10.3390/nu17060949
BibTeX
@article{Belloir2025,
author = {Belloir, Christine and Jeannin, Mathilde and Karolkowski, Adeline and Briand, Loïc},
title = {TAS1R2/TAS1R3 Single-Nucleotide Polymorphisms Affect Sweet Taste Receptor Activation by Sweeteners: The SWEET Project},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {6},
pages = {949},
doi = {10.3390/nu17060949}
}
EUVIMED